Literature DB >> 8685282

Adrenal secretion and major depression in 8- to 16-year-olds, II. Influence of co-morbidity at presentation.

J Herbert1, I M Goodyer, P M Altham, J Pearson, S M Secher, H M Shiers.   

Abstract

The association between high evening cortisol and low morning DHEA and the pattern of co-morbid diagnoses in 82 cases of major depressive disorder in 8- to 16-year-olds has been analysed. There was a significant association between the presence of high evening cortisol and co-morbid dysthymia. This was independent of age or sex. No positive association was found between the presence of low morning DHEA and any co-morbid diagnosis. However, co-morbid panic or phobic disorder was significantly associated with the absence of this endocrine abnormality. These findings suggest that specific endocrine disturbances may be associated with different patterns of co-morbidity during an episode of major depression in this age group.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8685282     DOI: 10.1017/s0033291700034656

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  10 in total

1.  Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity.

Authors:  V G Kimonides; N H Khatibi; C N Svendsen; M V Sofroniew; J Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 2.  Cognition in mania and depression: psychological models and clinical implications.

Authors:  Samuel R Chamberlain; Barbara J Sahakian
Journal:  Curr Psychiatry Rep       Date:  2004-12       Impact factor: 5.285

3.  Cortisol diurnal patterns, associations with depressive symptoms, and the impact of intervention in older adults: results using modern robust methods aimed at dealing with low power due to violations of standard assumptions.

Authors:  Rand R Wilcox; Douglas A Granger; Sarah Szanton; Florence Clark
Journal:  Horm Behav       Date:  2014-01-24       Impact factor: 3.587

4.  Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model Study.

Authors:  O Malkesman; T Asaf; L Shbiro; A Goldstein; R Maayan; A Weizman; N Kinor; E Okun; B Sredni; G Yadid; A Weller
Journal:  Adv Pharmacol Sci       Date:  2009-10-18

Review 5.  Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis.

Authors:  Nestor L Lopez-Duran; Maria Kovacs; Charles J George
Journal:  Psychoneuroendocrinology       Date:  2009-05-05       Impact factor: 4.905

Review 6.  Structural and functional plasticity of the human brain in posttraumatic stress disorder.

Authors:  J Douglas Bremner; Bernet Elzinga; Christian Schmahl; Eric Vermetten
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

7.  Concurrent and longitudinal associations of basal and diurnal cortisol with mental health symptoms in early adolescence.

Authors:  Elizabeth A Shirtcliff; Marilyn J Essex
Journal:  Dev Psychobiol       Date:  2008-11       Impact factor: 3.038

8.  Dismantling the relative effectiveness of core components of cognitive behavioural therapy in preventing depression in adolescents: protocol of a cluster randomized microtrial.

Authors:  Marieke W H van den Heuvel; Denise H M Bodden; Mirjam Moerbeek; Filip Smit; Rutger C M E Engels
Journal:  BMC Psychiatry       Date:  2019-06-27       Impact factor: 3.630

9.  Effectiveness and cost effectiveness of cognitive behavioral therapy (CBT) in clinically depressed adolescents: individual CBT versus treatment as usual (TAU).

Authors:  Yvonne Stikkelbroek; Denise Hm Bodden; Maja Deković; Anneloes L van Baar
Journal:  BMC Psychiatry       Date:  2013-11-21       Impact factor: 3.630

10.  Adolescent Depression and Negative Life Events, the Mediating Role of Cognitive Emotion Regulation.

Authors:  Yvonne Stikkelbroek; Denise H M Bodden; Marloes Kleinjan; Mirjam Reijnders; Anneloes L van Baar
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.